Article
Complement Therapeutics in Autoimmune Disease
3 Apr 2019
Abstract excerpt
Many autoimmune diseases are characterized by generation of autoantibodies that bind to host proteins or deposit within tissues as a component of immune complexes. The autoantibodies can activate the complement system, which can mediate tissue damage and trigger systemic inflammation. Complement inhibitory drugs may, therefore, be beneficial across a large number of different autoimmune diseases. Many new...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
